Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention

Fig. 1

Clinical outcomes in the follow-up CHD population. Kaplan-Meier curves for the cardiovascular adverse events. X axis represents the follow-up time and the Y axis represents cumulative survival. The P values were calculated using the log-rank tests. a Kaplan-Meier curves for the cardiovascular adverse events according to the quartiles of ApoB/A1 ratios; b Kaplan-Meier curves for the cardiovascular adverse events according to the quartiles of FRS: Q1(n = 457), Q2(n = 721), Q3(n = 603), Q4(n = 481). c Kaplan-Meier curves for the cardiovascular adverse events according to the quartiles of TC/HDL-c: Q1(n = 566), Q2(n = 568), Q3(n = 563), Q4(n = 565). No. of Events: Number of clinical outcomes in the month-points

Back to article page